NYSE:HUM - Humana Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$310.23 -5.45 (-1.73 %)
(As of 07/17/2018 09:40 AM ET)
Previous Close$315.68
Today's Range$309.72 - $313.8903
52-Week Range$229.84 - $319.44
Volume18,758 shs
Average Volume551,524 shs
Market Capitalization$43.66 billion
P/E Ratio26.49
Dividend Yield0.63%
Beta0.95
Humana logoHumana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000

Debt

Debt-to-Equity Ratio0.47
Current Ratio1.55
Quick Ratio1.55

Price-To-Earnings

Trailing P/E Ratio26.49
Forward P/E Ratio22.16
P/E Growth1.64

Sales & Book Value

Annual Sales$53.77 billion
Price / Sales0.79
Cash Flow$15.0015 per share
Price / Cash20.68
Book Value$68.89 per share
Price / Book4.50

Profitability

EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins3.36%
Return on Equity16.74%
Return on Assets5.60%

Miscellaneous

Employees45,900
Outstanding Shares137,680,000
Market Cap$43,661.72

The Truth About Cryptocurrencies

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Thursday, April 19th. Investors of record on Friday, June 29th will be given a dividend of $0.50 per share on Friday, July 27th. This represents a $2.00 annualized dividend and a yield of 0.63%. The ex-dividend date is Thursday, June 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana announced that its Board of Directors has authorized a stock buyback program on Friday, December 15th 2017, which authorizes the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company's board believes its stock is undervalued.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) released its quarterly earnings results on Wednesday, May, 2nd. The insurance provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.21 by $0.15. The insurance provider had revenue of $14.28 billion for the quarter, compared to the consensus estimate of $14.22 billion. Humana had a net margin of 3.36% and a return on equity of 16.74%. During the same quarter in the previous year, the company posted $2.75 earnings per share. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY18 earnings guidance on Thursday, May, 31st. The company provided earnings per share guidance of $13.70-14.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.97.

What price target have analysts set for HUM?

16 analysts have issued 12 month target prices for Humana's stock. Their predictions range from $221.00 to $362.00. On average, they expect Humana's stock price to reach $293.00 in the next twelve months. This suggests that the stock has a possible downside of 7.2%. View Analyst Ratings for Humana.

What is the consensus analysts' recommendation for Humana?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 5 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

What are Wall Street analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:
  • 1. According to Zacks Investment Research, "Shares of Humana have outperformed the industry year to date. The insurer is well-poised for growth on its strong government business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholders’ value. Humana’s sound balance sheet and a disciplined capital management remain major tailwinds. Following better-than-expected first-quarter results, the company provided a strong guidance for 2018. Also, the company has exited the individual commercial business effective Jan 1, 2018. Rising level of expenses persistently weighs on the bottom line. With respect to quarterly results, Humana’s first-quarter bottom line beat estimates on a favorable current-year medical utilization in Retail segment relative, lower tax rate and a positive impact of share buybacks." (5/31/2018)
  • 2. Cantor Fitzgerald analysts commented, "This morning, Humana announced it would acquire a 40% interest in Curo Health Services, a large, privately-held hospice company." (4/23/2018)

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
  • Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
  • Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 52)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)

Has Humana been receiving favorable news coverage?

Media coverage about HUM stock has trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Humana earned a media sentiment score of 0.21 on Accern's scale. They also gave headlines about the insurance provider an impact score of 46.14 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Humana's major shareholders?

Humana's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.30%), Mckinley Capital Management LLC Delaware (0.07%), NN Investment Partners Holdings N.V. (0.06%), Gulf International Bank UK Ltd (0.03%), Scout Investments Inc. (0.03%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, Scout Investments Inc., Clinton Group Inc., Fjarde AP Fonden Fourth Swedish National Pension Fund, Empowered Funds LLC, Gateway Investment Advisers LLC, Gulf International Bank UK Ltd and CHURCHILL MANAGEMENT Corp. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Which institutional investors are buying Humana stock?

HUM stock was purchased by a variety of institutional investors in the last quarter, including Bank of Montreal Can, NN Investment Partners Holdings N.V., Pensionfund DSM Netherlands, Pensionfund Sabic, State of Alaska Department of Revenue, Atlas Brown Inc., First Citizens Bank & Trust Co. and IFM Investors Pty Ltd. View Insider Buying and Selling for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $315.68.

How big of a company is Humana?

Humana has a market capitalization of $43.66 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.


MarketBeat Community Rating for Humana (NYSE HUM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  629 (Vote Outperform)
Underperform Votes:  706 (Vote Underperform)
Total Votes:  1,335
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.